4.0 Article

The Impact of Antimicrobial Resistance on Outcomes for Patients Undergoing Coronary Artery Bypass Graft and Valve Surgery: A Retrospective Cohort Study of Hospital Admissions Data from the National Inpatient Sample

Journal

MICROBIOLOGY RESEARCH
Volume 14, Issue 2, Pages 580-590

Publisher

MDPI
DOI: 10.3390/microbiolres14020040

Keywords

antimicrobial resistance; coronary artery bypass graft surgery; valve surgery; mortality; length of stay; cost

Categories

Ask authors/readers for more resources

A retrospective cohort study using data from the National Inpatient Sample in the United States was conducted to evaluate the proportion of patients undergoing cardiac surgery who had antimicrobial resistance. The study found that patients with antimicrobial resistance were more likely to be female and had a higher in-hospital mortality rate. Antimicrobial resistance significantly increased the length of stay and cost for patients.
Background: There is uncertainty regarding the impact of multidrug-resistant organisms on patients that undergo cardiac surgery. Methods: A retrospective cohort study was performed by using 2016-2019 data from the National Inpatient Sample in the United States to evaluate the proportion of admissions with a diagnosis of antimicrobial resistance who also underwent coronary artery bypass graft or valve surgery. Results: A total of 1,260,630 admissions were included in the analysis, of which 2045 (0.16%) had antimicrobial resistance. Compared to patients without resistance, those with antimicrobial resistance were more likely to be female (52.8% vs. 31.5%, p < 0.001), and die in a hospital (7.1% vs. 2.4%, p < 0.001). The length of stay and cost were significantly higher for patients with antimicrobial resistance (15 vs. 7 days and USD 69,135 vs. USD 43,740, respectively). Antimicrobial resistance was not associated with increased in-hospital mortality (OR 1.38; 95% CI 0.86-2.21, p = 0.18), although it was associated with an increase in length of stay (coefficient 7.65; 95% CI 6.91-8.39, p < 0.001), and cost (coefficient USD 25,240 [21,626-28,854], p < 0.001). Conclusions: Antimicrobial resistance in patients that undergo cardiac surgery is not common, yet its burden is substantial as it can double the length of stay and increase costs by more than USD 20,000.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available